GB0623971D0 - Modulation of prostaglandin/cyclooxygenase metabolic pathways - Google Patents
Modulation of prostaglandin/cyclooxygenase metabolic pathwaysInfo
- Publication number
- GB0623971D0 GB0623971D0 GB0623971A GB0623971A GB0623971D0 GB 0623971 D0 GB0623971 D0 GB 0623971D0 GB 0623971 A GB0623971 A GB 0623971A GB 0623971 A GB0623971 A GB 0623971A GB 0623971 D0 GB0623971 D0 GB 0623971D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- prostaglandin
- modulation
- metabolic pathways
- cyclooxygenase
- cyclooxygenase metabolic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (26)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0623971A GB0623971D0 (en) | 2006-11-30 | 2006-11-30 | Modulation of prostaglandin/cyclooxygenase metabolic pathways |
KR1020097013708A KR20090086272A (en) | 2006-11-30 | 2007-11-29 | Modulation of prostaglandin/cyclooxygenase metabolic pathways |
PT07870407T PT2097079E (en) | 2006-11-30 | 2007-11-29 | Modulation of prostaglandin/cyclooxygenase metabolic pathways |
RU2009124917/15A RU2448712C2 (en) | 2006-11-30 | 2007-11-29 | Prostaglandin/cyclooxygenase pathway modulation |
PCT/GB2007/004584 WO2008065408A2 (en) | 2006-11-30 | 2007-11-29 | Modulation of prostaglandin/cyclooxygenase metabolic pathways |
SI200731000T SI2097079T1 (en) | 2006-11-30 | 2007-11-29 | Modulation of prostaglandin/cyclooxygenase metabolic pathways |
JP2009538785A JP2010511028A (en) | 2006-11-30 | 2007-11-29 | Regulation of prostaglandin / cyclooxygenase metabolic pathways |
DK07870407.9T DK2097079T3 (en) | 2006-11-30 | 2007-11-29 | Modulation of prostaglandin / cyclooxygenase metabolic pathways |
EP07870407A EP2097079B1 (en) | 2006-11-30 | 2007-11-29 | Modulation of prostaglandin/cyclooxygenase metabolic pathways |
ES07870407T ES2390182T3 (en) | 2006-11-30 | 2007-11-29 | Modulation of prostaglandin / cyclooxygenase metabolic pathways |
NZ577075A NZ577075A (en) | 2006-11-30 | 2007-11-29 | Modulation of prostaglandin/cyclooxygenase metabolic pathways |
US12/516,772 US20100137270A1 (en) | 2006-11-30 | 2007-11-29 | Modulation of prostaglandin/cyclooxygenase metabolic pathways |
CA002670957A CA2670957A1 (en) | 2006-11-30 | 2007-11-29 | Modulation of prostaglandin/cyclooxygenase metabolic pathways |
CN200780050499.5A CN101594861B (en) | 2006-11-30 | 2007-11-29 | Modulation of prostaglandin/cyclooxygenase metabolic pathways |
AU2007327011A AU2007327011A1 (en) | 2006-11-30 | 2007-11-29 | Modulation of prostaglandin/cyclooxygenase metabolic pathways |
RS20120372A RS52453B (en) | 2006-11-30 | 2007-11-29 | Modulation of prostaglandin/cyclooxygenase metabolic pathways |
PL07870407T PL2097079T3 (en) | 2006-11-30 | 2007-11-29 | Modulation of prostaglandin/cyclooxygenase metabolic pathways |
EP09012181A EP2147673A1 (en) | 2006-11-30 | 2007-11-29 | Modulation of prostaglandin/cyclooxygenase metabolic pathways |
MX2009005753A MX2009005753A (en) | 2006-11-30 | 2007-11-29 | Modulation of prostaglandin/cyclooxygenase metabolic pathways. |
TW096145663A TWI414298B (en) | 2006-11-30 | 2007-11-30 | Modulation of prostaglandin/cyclooxygenase metabolic pathways |
ZA2009/03584A ZA200903584B (en) | 2006-11-30 | 2009-05-22 | Modulation of prostaglandin/cyclooxygenase metabolic pathways |
IL199013A IL199013A0 (en) | 2006-11-30 | 2009-05-27 | Compositions containing an agent which increases production of 15-deoxy-prostaglandin j2 for treating diseases associated with the prostaglandin/cyclooxygenase metabolic pathway |
NO20092455A NO20092455L (en) | 2006-11-30 | 2009-06-29 | Modulation of prostaglandin / cyclooxygenase metabolic pathways |
US13/566,136 US20130023504A1 (en) | 2006-11-30 | 2012-08-03 | Modulation of Prostaglandin/Cyclooxygenase Metabolic Pathways |
HRP20120687TT HRP20120687T1 (en) | 2006-11-30 | 2012-08-29 | Modulation of prostaglandin/cyclooxygenase metabolic pathways |
CY20121100870T CY1113367T1 (en) | 2006-11-30 | 2012-09-24 | CONSTRUCTION OF PROSTAGLAND / CYCLOGENATION METHODS |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0623971A GB0623971D0 (en) | 2006-11-30 | 2006-11-30 | Modulation of prostaglandin/cyclooxygenase metabolic pathways |
Publications (1)
Publication Number | Publication Date |
---|---|
GB0623971D0 true GB0623971D0 (en) | 2007-01-10 |
Family
ID=37671641
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB0623971A Ceased GB0623971D0 (en) | 2006-11-30 | 2006-11-30 | Modulation of prostaglandin/cyclooxygenase metabolic pathways |
Country Status (9)
Country | Link |
---|---|
CN (1) | CN101594861B (en) |
DK (1) | DK2097079T3 (en) |
ES (1) | ES2390182T3 (en) |
GB (1) | GB0623971D0 (en) |
NZ (1) | NZ577075A (en) |
PT (1) | PT2097079E (en) |
RS (1) | RS52453B (en) |
RU (1) | RU2448712C2 (en) |
SI (1) | SI2097079T1 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI713972B (en) * | 2019-01-14 | 2020-12-21 | 大江生醫股份有限公司 | The improving respiratory health probiotic strain, composition thereof and use thereof |
TWI692359B (en) * | 2019-02-25 | 2020-05-01 | 大江生醫股份有限公司 | Metabolite of lactic acid bacteria and use of the metabolite of lactic acid bacteria for protecting lungs |
CN111777613A (en) * | 2019-04-03 | 2020-10-16 | 中国药科大学 | Preparation and application of pyrimidinedione indole and pyridone indole compounds |
WO2020209576A1 (en) * | 2019-04-09 | 2020-10-15 | 경희대학교 산학협력단 | Pharmaceutical composition for prevention or treatment of spinal cord injury or spinal stenosis |
CN111394289B (en) * | 2019-12-20 | 2021-06-11 | 合肥康诺生物制药有限公司 | Genetically engineered bacterium and application thereof, and method for producing prostaglandin E2 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2363983A (en) * | 2000-06-29 | 2002-01-16 | Hunter Fleming Ltd | Protection against neuronal damage using 7-hydroxyepiandrosterone |
GB2363984A (en) * | 2000-06-29 | 2002-01-16 | Hunter Fleming Ltd | Protection against neuronal damage using 3-hydroxy-7 -hydroxy steroids and 3-oxo-7 -hydroxy steroids |
GB2378898A (en) * | 2001-08-14 | 2003-02-26 | Hunter Fleming Ltd | Prophylactic and therapeutic use of hydroxysteroids |
FR2829697B1 (en) * | 2001-09-14 | 2004-03-19 | Mayoly Spindler Lab | 7-HYDROXYL AND 7-KETONIC DERIVATIVES OF 3-HYDROXYLATED STEROID HORMONES FOR THE TREATMENT OF INFLAMMATORY OR FUNCTIONAL INTESTINAL DISEASES |
-
2006
- 2006-11-30 GB GB0623971A patent/GB0623971D0/en not_active Ceased
-
2007
- 2007-11-29 NZ NZ577075A patent/NZ577075A/en not_active IP Right Cessation
- 2007-11-29 ES ES07870407T patent/ES2390182T3/en active Active
- 2007-11-29 RS RS20120372A patent/RS52453B/en unknown
- 2007-11-29 DK DK07870407.9T patent/DK2097079T3/en active
- 2007-11-29 CN CN200780050499.5A patent/CN101594861B/en not_active Expired - Fee Related
- 2007-11-29 PT PT07870407T patent/PT2097079E/en unknown
- 2007-11-29 RU RU2009124917/15A patent/RU2448712C2/en not_active IP Right Cessation
- 2007-11-29 SI SI200731000T patent/SI2097079T1/en unknown
Also Published As
Publication number | Publication date |
---|---|
NZ577075A (en) | 2012-01-12 |
DK2097079T3 (en) | 2012-10-01 |
SI2097079T1 (en) | 2012-10-30 |
CN101594861B (en) | 2013-06-12 |
ES2390182T3 (en) | 2012-11-07 |
RS52453B (en) | 2013-02-28 |
PT2097079E (en) | 2012-09-24 |
RU2448712C2 (en) | 2012-04-27 |
RU2009124917A (en) | 2011-01-10 |
CN101594861A (en) | 2009-12-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL244116B (en) | Modulation of factor 11 expression | |
IL205536A0 (en) | Modulation of factor 7 expression | |
GB0700194D0 (en) | Humanisation of animals | |
EP2180787A4 (en) | Nitrated-fatty acids modulation of type ii diabetes | |
GB2456859B (en) | Instruction pre-coding of multiple instruction sets | |
HK1131130A1 (en) | Co-crystals of pyrrolidinones | |
EP2040730A4 (en) | Modulation of nkg2d | |
EP2279410A4 (en) | Methods of identifying anti-inflammatory compounds | |
AP2008004406A0 (en) | Methods of managing timberland | |
PL2133419T3 (en) | Uses of cyanophycin beta-dipeptides | |
IL193271A0 (en) | Modulation of bone formation | |
IL209035A0 (en) | Solid states states of o-desmethylvenlafaxine salts | |
ZA200903584B (en) | Modulation of prostaglandin/cyclooxygenase metabolic pathways | |
IL194775A0 (en) | Modulation of lipid rafts | |
AP2784A (en) | Methods of managing timberland | |
SI2097079T1 (en) | Modulation of prostaglandin/cyclooxygenase metabolic pathways | |
GB0816459D0 (en) | State of change estimate | |
GB2460009A8 (en) | Compounds and methods for the modulation of beta-1integrin function to mediate tissue repair | |
GB0718870D0 (en) | Modulation of RSK | |
EP2247746A4 (en) | Methods of monitoring metabolic pathways | |
AP2717A (en) | Mono-hydrochloric salts of an inhibitor of histonedeacetylase | |
IL206333A0 (en) | Control of an entity to be controlled by a control entity | |
GB0815433D0 (en) | Manufacture of cast panels | |
PL383760A1 (en) | New application of undecane-2-ol | |
PL383758A1 (en) | New application of undecane-2-on |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |